Thank you very much, Chair, Minister and honourable member, for the question.
In fact, one of the major investments that this supplementary discussion is about is a clinical trials fund, which will in fact begin to develop again the clinical trials expertise in this country and to support investigators such as Dr. Kobinger in the very early phases of drug trials.
It's a $250-million investment over three years to establish a pan-Canadian strategy and to assist with the biomanufacturing component. The investments required are being made as we speak to rebuild, as the minister has stated.
Thank you.